It is widely accepted that incident cardiovascular events in persons with a history of major atherosclerotic cardiovascular disease are largely preventable. 1,2 Most cardiovascular risk can be causally attributed to a finite number of modifiable risk factors including dyslipidemia, hypertension, diabetes mellitus, and tobacco consumption. Therapeutic interventions to reduce cardiovascular residual risk are increasingly directed at multiple treatment targets both in patients with established coronary heart disease and those with an intermediate-to-high risk of having a first event, particularly those with an elevated low-density lipoprotein (LDL) cholesterol level of 70 mg per deciliter (1.8 mmol per liter) or higher. 2,3 Over the . . .
Joanne FOODY (Wed,) studied this question.